While Arch Chemicals
What analysts say:
- Buy, sell, or hold?: Analysts generally think investors should hang on to Arch Chemicals, with half rating the stock a hold. Analysts don't like Arch Chemicals as much as competitor Koppers Holdings overall. Five out of six analysts rate Koppers Holdings a buy compared with one of two for Arch Chemicals. Wall Street has warmed to the stock over the past three months, with analysts increasing their endorsement from hold to moderate buy.
- Revenue Forecasts: On average, analysts predict $459.4 million in revenue this quarter. That would represent a rise of 4.1% from the year-ago quarter.
- Wall Street Earnings Expectations: The average analyst estimate is earnings of $1.82 per share. Estimates range from $1.75 to $1.90.
What our community says:
CAPS All-Stars are solidly behind the stock with 100% granting it an "outperform" rating. The community at large backs the All-Stars with 91.7% assigning it a rating of "outperform." Fools are gung-ho about Arch Chemicals, though the message boards have been quiet lately with only 27 posts in the past 30 days. Arch Chemicals has a bullish CAPS rating of five out of five stars that is about on par with the Fool community assessment.
Arch Chemicals' profit has risen year over year by an average of 39.9%. A year-over-year revenue increase last quarter snaps a streak of two consecutive quarters of revenue declines. Revenue rose 9% in the first quarter and fell 6.5% in the fourth quarter of the last fiscal year and 7.1% in the third quarter of the last fiscal year.
For all our Arch Chemicals-specific analysis, including earnings and beyond, add Arch Chemicals to My Watchlist.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.